Cancer therapy using a self-replicating RNA vaccine

Nature Medicine

Volumn 5, Issue 7, 1999, Pages 823-827

  Ying, Han ^a   Zaks, Tal Z ^a   Wang, Rong Fu ^a   Irvine, Kari R ^a   Kammula, Udai S ^a   Marincola, Francesco M ^a   Leitner, Wolfgang W ^a   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; RNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CANCER; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; DRUG MECHANISM; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA REPLICATION;

ANIMALS; ANTIBODY FORMATION; APOPTOSIS; B-LYMPHOCYTES; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; DENDRITIC CELLS; ENHANCER ELEMENTS (GENETICS); INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA REPLICASE; SEMLIKI FOREST VIRUS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; SEMLIKI FOREST VIRUS;

EID: 0033028791     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/10548     Document Type: Article

References (23)

1. Liu, M.A., Fu, T.M., Donnelly, J.J., Caulfield, M.J. & Ulmer, J.B. DNA vaccines. Mechanisms for generation of immune responses. Adv. Exp. Med. Biol. 452, 187-191 (1998).
2. Irvine, K.R., Rao, J.B., Rosenberg, S.A. & Restifo, N.P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156, 238-245 (1996).
3. Gurunathan, S. et al. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161, 4563-4571 (1998).
4. Atkins, G.J., Sheahan, B.J. & Liljestrom, P. Manipulation of the Semliki Forest virus genome and its potential for vaccine construction. Mol. Biotechnol. 5, 33-38 (1996).
5. Wang, M. et al. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154, 4685-4692 (1995).
6. Rosenberg, S.A. et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med. 4, 321-327 (1998).
7. Overwijk, W.W. et al. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc. Natl. Acad. Sci. USA 96, 2982-2987 (1999).
8. Rao, J.B. et al. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J. Immunol. 156, 3357-3365 (1996).
9. Berglund, P., Smerdou, C., Fleeton, M.N., Tubulekas, I. & Liljestrom, P. Enhancing immune responses using suicidal DNA vaccines. Nature Biotechnol. 16, 562-565 (1998).
10. Miller, D.K. The role of the Caspase family of cysteine proteases in apoptosis. Semin. Immunol. 9, 35-49 (1997).
11. Chappell, D.B., Zaks, T.Z., Rosenberg, S.A. & Restifo, N.P. Human melanoma cells do not express Fas (Apo-1/CD95) ligand. Cancer Res. 59, 59-62 (1999).
12. Zaks, T.Z., Chappell, D.B., Rosenberg, S.A. & Restifo, N.P. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J. Immunol. 162, 3273-3279 (1999).
13. Hariharan, M.J. et al. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol. 72, 950-958 (1998).
14. Albert, M.L, Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLs. Nature 392, 86-89 (1998).
15. Specht, J.M. et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186, 1213-1221 (1997).
16. Der, S.D., Yang, Y.L., Weissmann, C. & Williams, B.R. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283 (1997).
17. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. & Lanzavecchia, A. Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA. J. Exp. Med. 189, 821-829 (1999).
18. Restifo, N.P. The new vaccines: building viruses that elicit antitumor immunity. Curr. Opin. Immunol. 8, 658-663 (1996).
19. Pardoll, D.M. Cancer vaccines. Nature Med. 4, 525-531 (1998).
20. Rosenberg, S.A. et al. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens. J. Natl. Cancer Inst. 90, 1894-1900 (1998).
21. Mandl, C. W., Aberle, J. H, Aberle S. W, Holzmann H, Allison, S. L, and Heinz, F. X. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nature Med. 4(12), 1438-1440.(1998).
22. Dubensky, T. W., Polo, J. M. & Liu, M. A. Live virus vaccines: Something old, something new, something borrowed... Nature Med. 4, 1357-1358 (1998).
23. Fink, L. et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Med. 4, 1329-1333 (1998).